NM_003998.4:c.408-248G>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_003998.4(NFKB1):​c.408-248G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.583 in 151,932 control chromosomes in the GnomAD database, including 25,981 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.58 ( 25981 hom., cov: 32)

Consequence

NFKB1
NM_003998.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.394

Publications

18 publications found
Variant links:
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]
NFKB1 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 12
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 4-102576628-G-A is Benign according to our data. Variant chr4-102576628-G-A is described in ClinVar as Benign. ClinVar VariationId is 1225045.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.654 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NFKB1NM_003998.4 linkc.408-248G>A intron_variant Intron 6 of 23 ENST00000226574.9 NP_003989.2 P19838-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NFKB1ENST00000226574.9 linkc.408-248G>A intron_variant Intron 6 of 23 1 NM_003998.4 ENSP00000226574.4 P19838-2
NFKB1ENST00000505458.5 linkc.405-248G>A intron_variant Intron 6 of 23 1 ENSP00000424790.1 P19838-1

Frequencies

GnomAD3 genomes
AF:
0.583
AC:
88526
AN:
151814
Hom.:
25966
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.586
Gnomad AMI
AF:
0.630
Gnomad AMR
AF:
0.515
Gnomad ASJ
AF:
0.658
Gnomad EAS
AF:
0.522
Gnomad SAS
AF:
0.673
Gnomad FIN
AF:
0.545
Gnomad MID
AF:
0.712
Gnomad NFE
AF:
0.595
Gnomad OTH
AF:
0.602
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.583
AC:
88564
AN:
151932
Hom.:
25981
Cov.:
32
AF XY:
0.580
AC XY:
43067
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.585
AC:
24230
AN:
41410
American (AMR)
AF:
0.514
AC:
7850
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.658
AC:
2282
AN:
3466
East Asian (EAS)
AF:
0.522
AC:
2692
AN:
5160
South Asian (SAS)
AF:
0.674
AC:
3243
AN:
4814
European-Finnish (FIN)
AF:
0.545
AC:
5749
AN:
10552
Middle Eastern (MID)
AF:
0.711
AC:
209
AN:
294
European-Non Finnish (NFE)
AF:
0.595
AC:
40461
AN:
67962
Other (OTH)
AF:
0.606
AC:
1276
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1900
3801
5701
7602
9502
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
754
1508
2262
3016
3770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.586
Hom.:
5451
Bravo
AF:
0.578
Asia WGS
AF:
0.572
AC:
1993
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.75
DANN
Benign
0.65
PhyloP100
-0.39
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs230541; hg19: chr4-103497785; API